Microfluidic Generation of Exosome‐Mimetic Nanoparticles for Scalable Production and Enhanced Therapeutic Efficacy
Small · 2025-10 · 21 (42)
DOI: 10.1002/smll.202506162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025-09. Verfasst von Jaejeung Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Mechanical Engineering, Yonsei University, Seoul, 03722, Republic of Korea. Hauptthemen laut MEDLINE: Exosomes, Nanoparticles, Microfluidics. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF), Ministry of SMEs and Startups, National Research Foundation of Korea (NRF); Commercialization Promotion Agency for R&D Outcomes(COMPA).
Abstract (Originalsprache)
Exosomes are nanoscale lipid‐bilayer vesicles that mediate intercellular communication by delivering bioactive molecules such as nucleic acids and proteins. Among them, exosomes derived from salivary gland epithelial stem cells (sgESC‐Exos) exhibit antifibrotic effects in salivary gland models through the delivery of antifibrotic microRNAs, such as miR‐1290 and miR‐3162. However, their clinical translation is hindered by low production yield and particle heterogeneity. To address these challenges, exosome‐mimetic nanoparticles (ENPs) are developed that mimic the lipid composition and therapeutic cargoes of sgESC‐Exos using a microfluidic chip integrated with a reverse‐Tesla structured micromixer. The microfluidic platform facilitates efficient mixing and self‐assembly of lipid and aqueous phases, resulting in uniform ENPs with effective encapsulation of nucleic acids. The resulting ENPs exhibit physicochemical properties similar to exosomes, including comparable size distribution and structural features. Moreover, they demonstrate efficient encapsulation of exosomal miRNAs and more uniform physicochemical properties than sgESC‐Exos, contributed to enhanced therapeutic efficacy, with ≈21‐fold higher cellular uptake and two‐fold faster wound closure rate. These findings highlight the potential of microfluidics‐based bottom‐up synthesis as a robust platform for exosome‐inspired nanomedicine, addressing key limitations of exosomes and paving the way for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Mechanical Engineering, Yonsei University, Seoul, 03722, Republic of Korea.
- The DABOM Inc., Seoul, 03722, Republic of Korea.
- Department of Otorhinolaryngology, College of Medicine, Yonsei University, Seoul, 03722, Republic of Korea.
- Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, 07985, Republic of Korea.
- Department of Biomedical Technology, Kangwon National University, Chuncheon-si, Gangwon-do, 24341, Republic of Korea.
- Department of Integrated Medicine, Yonsei University, Seoul, 03722, Republic of Korea.
ORCID-Profile: Hyo-Il Jung
Förderung
- National Research Foundation of Korea (NRF)
- Ministry of SMEs and Startups
- National Research Foundation of Korea (NRF); Commercialization Promotion Agency for R&D Outcomes(COMPA)
Zitieren
APA
Kim, J., Lee, D. H., Seo, H., Lee, H. J., Kim, G., Nie, C., Hong, Y., Yoon, Y. J., Lim, J. Y., Park, S. J., Yang, J. Y., Choi, S., Park, S., & Jung, H. I. (2025). Microfluidic Generation of Exosome‐Mimetic Nanoparticles for Scalable Production and Enhanced Therapeutic Efficacy. Small, 21(42). https://doi.org/10.1002/smll.202506162
Vancouver
Kim J, Lee DH, Seo H, Lee HJ, Kim G, Nie C, et al. Microfluidic Generation of Exosome‐Mimetic Nanoparticles for Scalable Production and Enhanced Therapeutic Efficacy. Small. 2025;21(42). doi:10.1002/smll.202506162
BibTeX
@article{Kim2025,
author = {Kim, Jaejeung and Lee, Do Hyun and Seo, Hyunjo and Lee, Hyun-Jin and Kim, Geonha and Nie, Cheng and Hong, Yongpyo and Yoon, Yeo-Jun and Lim, Jae-Yol and Park, Seong Jun and Yang, Ji Yeong and Choi, Seoyeon and Park, Sunyoung and Jung, Hyo-Il},
title = {Microfluidic Generation of Exosome‐Mimetic Nanoparticles for Scalable Production and Enhanced Therapeutic Efficacy},
journal = {Small},
year = {2025},
volume = {21},
number = {42},
doi = {10.1002/smll.202506162}
}
EUVIMED